Cited by 807Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, Steve R., Ho, Carolyn Y., Asif, Irfan M., Balaji, Seshadri, Burke, Michael A., Day, Sharlene M., Dearani, Joseph A., Epps, Kelly C., Evanovich, Lauren, Ferrari, Victor A., Joglar, José A., Khan, Sadiya S., Kim, Jeffrey J., Kittleson, Michelle M., Krittanawong, Chayakrit, Martinez, Matthew W., Mital, Seema, Naidu, Srihari S., Saberi, Sara, Semsarian, Christopher, Times, Sabrina, Waldman, Cynthia Burstein·2024·Circulation

DOI 10.1161/cir.0000000000001250

Open this paper in CoChat — free account

Abstract

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001250

Cites

518 of 518 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686

Show all 514 references

Research works printed but not linked: 227

Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.
Animal Studies-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/54.
Guidelines-Broad-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/75.
Guidelines-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/77.
RCT/ CCT-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/108.
SR/ MA/ HTA/ ITC-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022: Accessed September 14, 2022. https://searchfilters.cadth.ca/link/99.
10.1016/s0025-6196(11)64198-0 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1001/jamacardio.2015.0354 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1016/j.jacc.2015.01.019 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1016/j.jacc.2018.10.007 · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ehjci/jew313 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.01.071 · DOI
10.1016/j.jacc.2012.03.076 · DOI
10.1016/j.jacc.2010.11.002 · DOI
10.1016/j.echo.2011.03.006 · DOI
10.1161/circulationaha.107.698985 · DOI
10.1016/j.jcin.2011.02.014 · DOI
10.1016/j.amjcard.2007.09.111 · DOI
10.1161/01.cir.0000097110.55312.bf · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ejechocard/jeq063 · DOI
10.1093/ehjci/jew313 · DOI
10.1136/hrt.2007.126003 · DOI
10.1056/nejmoa021332 · DOI · Paper page
10.1016/s0002-9149(99)80416-0 · DOI
10.1161/01.cir.0000162460.36735.71 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1161/hcg.0000000000000054 · DOI
10.1093/eurheartj/ehq271 · DOI
10.1016/j.jacc.2012.02.068 · DOI
10.1161/circgen.117.001896 · DOI · Paper page
10.1161/circulationaha.114.013478 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1016/j.hrthm.2011.07.017 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1161/circgenetics.116.001620 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jacc.2015.01.019 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.118.037264 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jpeds.2017.03.033 · DOI
10.1093/eurheartj/ehr092 · DOI · Paper page
10.1148/radiol.2018180339 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.echo.2011.03.002 · DOI
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.120.047235 · DOI
10.1111/cge.13157 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1161/circulationaha.122.062699 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1001/jamacardio.2019.2861 · DOI
10.1001/jamacardio.2018.0789 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1177/2047487317702519 · DOI
10.1161/circheartfailure.113.000414 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1111/chd.12286 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1111/cge.13157 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.122.062699 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1056/nejm200006153422403 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1017/s1047951105001824 · DOI
10.1038/nrcardio.2017.6 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1001/jama.298.4.405 · DOI
10.1016/j.ahj.2013.06.009 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1093/eurheartj/ehq308 · DOI
10.1056/nejm200006153422403 · DOI
10.1016/j.jacc.2004.12.067 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1093/eurheartj/eht439 · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2013.01.037 · DOI
10.1177/2047487317702519 · DOI
10.1007/s00246-011-9967-y · DOI
10.1016/s0735-1097(98)00493-8 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1007/s00246-013-0676-6 · DOI
10.1161/circulationaha.115.017633 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jcmg.2016.02.031 · DOI
10.1016/j.jacc.2018.05.060 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1161/circulationaha.112.136085 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1016/j.amjcard.2020.04.042 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1016/j.jacc.2009.03.051 · DOI
10.1016/j.jacc.2013.01.037 · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/cir.0000000000000628 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.jacc.2015.06.1333 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.amjcard.2013.01.340 · DOI
10.1016/j.jcmg.2013.08.010 · DOI
10.1001/jamacardio.2016.0252 · DOI
10.1016/j.jtcvs.2018.11.148 · DOI
10.1016/j.mayocp.2018.07.022 · DOI
10.1016/j.jacc.2016.07.735 · DOI · Paper page
10.1016/j.echo.2018.10.011 · DOI
10.1136/hrt.2007.118018 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1161/01.cir.0000162460.36735.71 · DOI
Liebregts, M, Vriesendorp, PA, Mahmoodi, BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:896–905.
10.1536/ihj.27.701 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1161/01.cir.0000097110.55312.bf · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/circulationaha.105.583500 · DOI
10.1093/eurheartj/ehq136 · DOI
10.1161/circheartfailure.114.002248 · DOI · Paper page
10.1253/circj.cj-16-0432 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1016/s0140-6736(20)31792-x · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1016/j.ejheart.2008.03.006 · DOI
Gu, M, Jin, H, Hua, W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol. 2017;14:238–244.
10.1016/j.jacc.2017.11.040 · DOI
10.1093/europace/euw327 · DOI
Rowin, EJ, Mohanty, S, Madias, C, et al. Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol EP. 2019;5:131–133.
10.1136/heartjnl-2013-305471 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1161/circheartfailure.114.001843 · DOI · Paper page
10.1016/s2213-8587(14)70241-4 · DOI
10.1016/j.amjcard.2016.08.092 · DOI
10.1111/jce.12982 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1016/j.jacc.2005.01.012 · DOI · Paper page
10.1161/jaha.116.005152 · DOI
10.1016/j.amjcard.2003.10.025 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1161/circheartfailure.114.001435 · DOI
10.1161/circep.110.957290 · DOI

200 of 227 shown

Sorted by citations

Items 601–700 of 806

Editorial commentary: The vulnerable ventricle: Recognizing suicide left ventricle after aortic valve intervention
Divya, D., & Dalal, N. (2026) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2026.03.008
Evaluating left ventricular function and myocardial fibrosis in hypertrophic obstructive cardiomyopathy with corrected myocardial work
Zhang, X., Fang, L., Xie, Y., Li, Y., Li, H., Liu, M., Sun, C., Yang, Y., Zhang, R., Xu, J., et al. (2026) · Echo Research and Practice · doi:10.1186/s44156-026-00113-7
Obstructive Hypertrophic Cardiomyopathy and Interarterial Anomalous Aortic Origin of the Right Coronary Artery (AAORCA) Presenting With Syncope: Multimodal Diagnostic Assessment and Individualized Management
Moyambi, J. B., IsmaIl, A. A. S., Jalal, T., Meftout, B., & Abdenasser, D. (2026) · Cureus · doi:10.7759/cureus.106361
Emerging treatments in hypertrophic cardiomyopathy: a focus on cardiac myosin inhibitors
Shah, S., Abusafia, M., Keen, S., & Desai, M. Y. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2655420
Atrial electrophysiology in hypertrophic cardiomyopathy: current insights and knowledge gaps
Kliś, M., Williams, S. E., O'Neill, M. D., & Khalique, Z. (2026) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-026-02303-z
Sportempfehlungen bei Kardiomyopathien
Wernhart, S., & Akbulut, C. (2026) · Aktuelle Kardiologie · doi:10.1055/a-2804-4226
Efficacy and safety of mavacamten in non-obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis of randomized trials
Abdullah, M., Thalib, H. I., Tahir, M. B., Khalid, N., Mushtaq, A., Afzal, M. A., Moore, M. D., Sharma, N. D., Muddassir, S. M., Ayers, M. P., et al. (2026) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2026.101908
The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis
Przybylski, R., Norrish, G., Claggett, B. L., Ashley, E. A., Bhole, V., Day, S. M., Donne, G. D., Fernández, A., Girolami, F., Gray, B. R., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.078843
Self-citation
Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients
Veselka, J., Gimeno, J. R., Abraham, T. P., Barriales-Villa, R., Claggett, B. L., COATS, C. J., Hegde, S. M., Januzzi, J. L., Masri, A., Miao, Z. M., et al. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.04.009
Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Integrating Pharmacological, Device, and Advanced Heart Failure Therapies
Tajdini, M., Tavakoli, K., Jenkin, S. C., Keykhaei, M., & Hahn, V. S. (2026) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2026.03.030
Prognostic factors for cardiovascular-related mortality in pediatric hypertrophic cardiomyopathy: a retrospective cohort study with survival analysis and X-tile stratification
Li, S.-G., Zhang, N., Su, D., Chen, C., Qin, S., Ye, B., & Pang, Y. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1825591
Diffuse hypertrophic obstructive cardiomyopathy complicated by apical ventricular aneurysm and excessive left ventricular trabeculation: a case report
Li, Y., Jia, N., Li, X., Dai, J., & Liu, D. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1753832
Beyond weight loss in hypertrophic cardiomyopathy: metabolic therapy and the evolving treatment paradigm
Boettger, P., & Sossalla, S. T. (2026) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcag064
Why the septum thickens in hypertrophic cardiomyopathy
Federspiel, J. M., Reil, J., & Sequeira, V. (2026) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2026.100849
Disopyramide
Wilborn, T. W., Fasinu, P. S., & Coric, T. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44037-3.00590-x
Association of Left Ventricular Mass with Hospital Length of Stay and Glucose Infusion Needs in Infants of Diabetic Mothers
Kannan, A., Spray, B. J., Theisen, B. W., Daily, J. A., Rumpel, J. A., Dajani, N. K., & Bolin, E. H. (2026) · American Journal of Perinatology · doi:10.1055/a-2856-1179
Mavacamten in Obstructive Hypertrophic Cardiomyopathy: National Insights on Access and Safety Profile From Real‐World Data
Fath, A. R., Aglan, A., Naidu, S. S., Mader, M. J., CHILTON, R. J., Elgendy, I. Y., Maron, M. S., & Rowin, E. J. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.045994
Self-citation
Assessment of left atrioventricular coupling index in hypertrophic cardiomyopathy: improving risk stratification with cardiac magnetic resonance (CMR)
Zhang, D., Qian, Y., Gu, Z., Zhao, L. H., Wu, L., & Wang, Y. (2026) · Clinical Radiology · doi:10.1016/j.crad.2026.107369
Multicellular Cross Talk and Therapeutic Vaccines in Heart Failure
Katoh, M., Nomura, S., Ko, T., Komuro, J., Hayashi, H., Nakagami, H., & Komuro, I. (2026) · Physiology · doi:10.1152/physiol.00007.2026
Unusual hypertrophic cardiomyopathy with severe right ventricular outflow tract obstruction and two septal aneurysms: a case report
Sun, Y., Liu, S., & Li, J. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05872-z
Combined Mitral Valve Surgery in Hypertrophic Obstructive Cardiomyopathy Patients Undergoing the Modified Morrow Procedure: Impact on Kansas City Cardiomyopathy Questionnaire Scores and Management
Li, X., Zhang, X., Zhang, K., Li, X. P., Chong, Y., Zhang, X., Cui, H., Ren, C., Lai, Y., & He, M. (2026) · The Heart Surgery Forum · doi:10.31083/hsf49410
Getting ahead of sudden cardiac arrest in pediatric hypertrophic cardiomyopathy
Chiu, S., Tseng, W., Juang, J. J., Lee, N., Chen, W., & Wu, M. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2669536
Cardiac Myosin Inhibitors (CMIs) and Surgical Referral in Patients with Hypertrophic Cardiomyopathy
Ferraresi, B., Nenna, A., Jawabra, M., Corrado, D., Faggiano, A., Carugo, S., Dominici, C., Casali, G., Chello, M., & Lusini, M. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13050187
Does the genotype of hypertrophic cardiomyopathy impact the outcomes of septal myectomy?
Karadzha, A., Schaff, H. V., Sawma, T., Todd, A. L., Geske, J. B., Dearani, J. A., Bos, M., Ackerman, M., Ommen, S. R., & Maleszewski, J. (2026) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2026.04.051
Self-citation
When Postoperative Gradients No Longer Mean the Same Thing: Interpreting Gradient–Anatomy Dissociation After Septal Myectomy
Yan, L., & Guo, A. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.05.022
Experiences, Values and Goals of People Living with Obstructive Hypertrophic Cardiomyopathy: Exploratory Patient Interviews
Fifer, S. J., Pendleton, A., Ingles, J., Godsell, J., Zhong, Y., & Krause, T. (2026) · Patient Preference and Adherence · doi:10.2147/ppa.s554609
Cerebrovascular disease: clinical, diagnostic and therapeutic approach to stroke
Erhardt, G. A., & Taborda, M. (2024) · International Journal of Neurology · doi:10.62486/ijn2024150
Association between Left Ventricular Late Gadolinium Enhancement and Left Atrial Function in Hypertrophic Cardiomyopathy: A Cardiac MR-Feature Tracking StudyPreprint
Liu, W., Gao, Y., Li, Q., Feng, Z., Zhao, Y., Shi, J., Li, W., Lin, J., Qiao, Z., Lu, L., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9364182/v1
Cas13-Mediated RNA Base Editing for the Treatment of Hereditary Hypertrophic Cardiomyopathy
Hu, Q. P., Lin, J. Y., Cui, H., Zhao, X., Wu, M., Wei, S., Deng, M., Wang, B., Liu, T., Gao, X., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.076905
Evolving epidemiology of cardiomyopathies at a national referral centre: a 30-year longitudinal study
Colio, F., Franco, A. D., Argirò, A., Mazzoni, C., Carrassa, G., Sasso, L., Targetti, M., Fornaro, A., Garofalo, M., Dei, L., et al. (2026) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcag080
Integrated 99mTc-PYP Scintigraphy, 18F-FDG PET/CT, and Cardiac Magnetic Resonance in Suspected Infiltrative and Inflammatory Cardiomyopathy: Initial Experience
Akhter, A., Biswas, S. K., Islam, A. K. M. M., Sharmin, S., Rahman, F., Afrin, R., Hossain, S., Islam, S., Alam, S., Hasan, T., et al. (2026) · Bangladesh Journal of Nuclear Medicine · doi:10.3329/bjnm.v29i1.89276
Serum chloride level and outcome in patients with hypertrophic cardiomyopathy
Shirotani, S., Minami, Y., Kanbayashi, K., Higuchi, S., Koyanagi, C., Haruki, S., & Yamaguchi, J. (2026) · Journal of Cardiology · doi:10.1016/j.jjcc.2026.05.003
Anesthetic management of transapical beating-heart septal myectomy in a child with obstructive hypertrophic cardiomyopathy: a case report
Yu, H., Cheng, L., & Zheng, H. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-03932-7
Miocardiopatía hipertrófica en centros no especializados: una oportunidad para ordenar la práctica real
Fernández, A. (2026) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v94.i2.20995
Prognostic Impact of LGE Granularity Using CMR in End‑Stage Hypertrophic Cardiomyopathy
Hudelo, J., Garot, J., Toupin, S., Duhamel, S., Sanguineti, F., Garot, P., Hovasse, T., Champagne, S., Unterseeh, T., Akodad, M., et al. (2026) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.125.019408
Diagnostic Approach to Left Ventricular Hypertrophy: A Review
Banthiya, S., Agrawal, A., Rai, D., Chowdhury, M., Pan, S., & Naidu, S. S. (2026) · US Cardiology Review · doi:10.15420/usc.2024.65
Self-citation
Long‐Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER‐CN Study
Tian, Z., Li, X., Li, L., Zhang, Q., Wang, J., Shi, Y. Q., Peng, D. Q., Ma, W., Yang, P., Cheng, X., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.046251
Advances and unmet needs in pharmacologic therapy for pediatric heart failure: Insights from the 2025 International Society for Heart and Lung Transplantation Guidelines
Das, B. B. (2026) · Annals of Pediatric Cardiology · doi:10.4103/apc.apc_85_26
Pharmacologic therapies for hypertrophic cardiomyopathy: The past, the present, and the future
Halațiu, V.-B., Cozac, D. A., & Scridon, A. (2026) · JRSM Cardiovascular Disease · doi:10.1177/20480040261431384
Sudden cardiac death in hypertrophic cardiomyopathy: can we really influence the risks
Игоревич, С. Г., Gilevskaya, Y. S., Lysenko, A. V., Вавилов, А. В., & IuV, B. (2026) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio20261903153
Optimizing imaging techniques in hypertrophic cardiomyopathy: challenges and opportunities
Keen, S., & Desai, M. Y. (2026) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyag099
Recurrent left ventricular outflow tract obstruction after septal myectomy: analysis of causes and secondary correction
Lysenko, A. V., Gilevskaya, Y. S., Игоревич, С. Г., & Belov, Y. (2026) · Russian Journal of Cardiology and Cardiovascular Surgery · doi:10.17116/kardio20261903157
Is Hemodynamic Gain Index (HGI) During Exercise a Novel Approach to Risk Stratification in Patients With Hypertrophic Cardiomyopathy?
Wolfel, E. E. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.05.027
基于心脏磁共振影像组学及特征追踪技术解析肥厚型心肌病心肌异质性的新视角
陆熠婷, Zhou, Y., 谷, 凌., 严, 翼., 谢, 晓., & 张, 瑜. (2026) · 临床诊断与治疗杂志 · doi:10.62177/fcdt.v2i3.1455
A large-scale single-nucleus resource reveals a cardiomyocyte-like fibroblast and stage-specific remodeling across cardiomyopathies
Tang, Q., Li, X., Fan, X., Zheng, C., Ma, H., Luo, R., Tang, Y., Liu, S., Fan, C., Zhang, Y., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04954-1
Left Ventricular Hypertrabeculation: Historical Evolution, Diagnostic Pitfalls, and a Pragmatic Clinical Approach
Parodi, A., Martini, M., Cecere, A., Iezzi, L., Rigato, I., & Bauce, B. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm51235
Atrial fibrillation prediction in patients with hypertrophic cardiomyopathy based on long-term follow-up data and machine learning model
Ding, W., Li, G.-C., Dong, H.-Y., Zong, D.-F., Ai, X.-J., Xia, Y.-L., Yang, X.-L., & Dong, Y.-X. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1814593
Safety and efficacy of mavacamten in obstructive versus non-obstructive hypertrophic cardiomyopathy: a meta-analysis of randomised controlled trials
Alazzam, A. Y., Almajdoubeh, O., Barakat, A., Abuhamdan, L., Alsboul, A., Othman, A. S., & Mustafa, M. T. (2026) · Heart · doi:10.1136/heartjnl-2025-327651
Mitral Transcatheter Edge-to-Edge Repair in Non-Surgical Candidates with Hypertrophic Obstructive Cardiomyopathy: Clip It, or Ablate It?
Chourdakis, E., Mashayekhi, K., Schäfer, U., & Katsouras, C. S. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13060255
2026 focsused update incorporated into the Japanese society of echocardiography 2023 practice guidance for the implementation of stress echocardiography “stress echocardiography using the Valsalva maneuver”
Hirano, Y., Iwano, H., Ohara, T., Okura, H., Amano, M., Umeda, H., Obokata, M., Kagiyama, N., Daimon, M., Tanaka, H., et al. (2026) · Journal of Echocardiography · doi:10.1007/s12574-026-00735-0
Cardiac magnetic resonance imaging parameters predict new-onset symptoms of heart failure in hypertrophic cardiomyopathy
da Silva, D. S., Vizentin, V. K., Félix, I. F., Maanja, M., Lahori, S., Pasupathy, K. S., Ommen, S. R., Geske, J. B., Giudicessi, J. R., Araoz, P. A., et al. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvag160
Self-citation
Supranormal Ejection Fraction as a Clinical Red Flag: Differentiating Hemodynamic Stress From Intrinsic Cardiomyopathy in Heart Failure
Chen, Y., Su, X., Jiang, J., Tang, J., Qiu, Z., Yang, W., & Jin, W. (2026) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2026.100726
Differential diagnosis of nonobstructive hypertrophic cardiomyopathy and cardiac amyloidosis with atypical delayed enhancement patterns on magnetic resonance imaging: the role of myocardial strain analysis
Magomedova, Z. M., Никифорова, Т. В., Shchekochikhin, D., Pershina, E. S., Kovalev, K., Abdulmazhidova, K. S., Charaya, K. V., Евгеньевич, Г. А., Sinitsyn, V. E., & Andreev, D. A. (2026) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2026-4598
Systematic Review Certainty of Evidence and Procedural Durability of Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: An Umbrella Review of Meta-Analyses
Simão, A. C., de Oliveira, M. B. G., & Menezes, A. D. S. (2026) · Cardiology · doi:10.1159/000552974
Digital Health and Wireless Solutions: Integrating AI, LLMs and Multimodal Health Data for Next-Generation Decision Support
Särestöniemi, M., Singh, D., Jarva, E., & Reponen, J. (2026) · Communications in computer and information science · doi:10.1007/978-3-032-28819-6
Comprehensive left ventricular outflow tract reconstruction in hypertrophic cardiomyopathy
Lysenko, A. V., Gilevskaya, Y. S., Игоревич, С. Г., & IuV, B. (2026) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202606129
Prognostic Risk Stratification of Hypertrophic Cardiomyopathy
Dang, L. N. K., Agakov, F. V., Hyttinen, J., Olivotto, I., & van Gils, M. (2026) · Communications in computer and information science · doi:10.1007/978-3-032-28819-6_22
Impact of Anterior Mitral Leaflet Length on the Efficacy of Intracardiac Echocardiography-Guided Endocardial Septal Ablation for HOCM
Ling, Y., Yu, T., Xu, Y., Wan, Q., Pang, Y., Liu, G., Chaofeng, C., Cheng, K., Zhu, W., Chen, Q., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13060274
A pragmatic clinical risk score for adverse outcomes in hypertrophic cardiomyopathy using routine laboratory and bedside variables
Chen, Z.-Y., & Chen, J.-H. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06127-7
Real-time identification of aetiology in patients able to undergo transoesophageal echocardiography with non-traumatic out-of-hospital cardiac arrest in China: a prospective, single-centre exploratory study
Du, P., Liu, X., Zheng, Q., Lai, L., Liu, S., & Lin, J. (2026) · Emergency Medicine Journal · doi:10.1136/emermed-2025-215837
Effect of cardiac myosin inhibitors on cardiac structure and myocardial fibrosis in obstructive hypertrophic cardiomyopathy: a meta-analysis of cardiac magnetic resonance outcomes
Lu, Y., Zhu, Y., & Tian, Z. (2026) · Clinical Radiology · doi:10.1016/j.crad.2026.107416
Implementation of a dedicated hypertrophic cardiomyopathy program and adherence to guideline-recommended care
Modi, R. D., Gupta, J., Chaudhry, H., Cheng, E., & Steitieh, D. (2026) · Next research. · doi:10.1016/j.nexres.2026.102017
Systolic anterior motion of an anomalous papillary muscle in obstructive hypertrophic cardiomyopathy
Panatpur, A., & Doan, T. T. (2026) · Cardiology in the Young · doi:10.1017/s1047951126113626
Postoperative changes in QRS duration and long-term mortality after septal myectomy
Kitsuka, T., Peffley, N. D., Wieruszewski, P. M., Daly, R. C., & Schaff, H. V. (2026) · JTCVS Open · doi:10.1016/j.xjon.2026.101935
Integrating Genotyping and Left Atrial Strain Analysis Enhances Risk Stratification in Hypertrophic Cardiomyopathy
Hiruma, T., Nakanishi, K., Inoue, S., Nomura, S., Yoshida, Y., Dai, Z., Abe, R., Yamada, T., Fujita, K., Katoh, M., et al. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.102863
Impact of genotype on histopathology and clinical characters in a Chinese cohort with obstructive hypertrophic cardiomyopathy
Yin, K., Sun, Y., Zhao, H., Yang, H., Meng, Y., Li, T., Li, W., Han, B., Liu, X., Wang, S., et al. (2026) · Genomics · doi:10.1016/j.ygeno.2026.111286
Significance of the Echocardiographic Assessment of Longitudinal Left Ventricular Systolic Function in Children and Adolescents with Hypertrophic Cardiomyopathy
Kalanj, J., Jovanović, I., Djukić, M., Parezanović, V., Stefanović, I., Bijelic, M., Pavlovic, A. S., Cukanovic, N., Zekovic, L., Jovanović, I., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15134911
Assessing the need for cardioverter defibrillator implantation in hypertrophic cardiomyopathy: patient association’s perspectives
Maurizi, N., Olivotto, I., & Cecchi, F. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag412
Recurrent Angina in Apical Hypertrophic Cardiomyopathy Associated With Myocardial Bridging of the Posterior Descending Artery
Shah, M. G., Batta, Y., & Fabrizio, C. (2026) · Cureus · doi:10.7759/cureus.111722
Dynamic electrophysiological changes after ethanol ablation for ventricular septum: Insights from a septal pacing lead
Yamashita, S., Yamaji, Y., Iwasaki, M., & Okuda, M. (2026) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2026.06.031
Clinical Course and Predictors of Heart Failure in Asymptomatic Obstructive Hypertrophic Cardiomyopathy
Schulz, A., Maron, M. S., Peng, L. W., Maron, B. A., Amyar, A., Ngo, L. H., Olivotto, I., Chan, R. H. M., Manning, W. J., Rowin, E. J., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.048066
Mavacamten in adolescent obstructive hypertrophic cardiomyopathy: SCOUTing a way forward
Bennetts, J. D., Ngo, D. T. M., Cheema, B. S., Hosseini, K., Verheyen, N., Santner, V., Tomasoni, D., & Sverdlov, A. L. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10655-x
Clinical and Genetic Characteristics of 114 Russian Children with a Monogenic Non-Sarcomeric Hypertrophic Cardiomyopathy Phenotype
Gandaeva, L. A., Kaverina, V. G., Basargina, E. N., Pushkov, A. A., Вячеславовна, С. И., & Savostyanov, K. V. (2026) · L O Badalyan Neurological Journal · doi:10.46563/2686-8997-2026-7-1-226
Sex-disaggregated data in hypertrophic cardiomyopathy: a targeted literature review, meta-analysis and primary cohort study
Lim, V. G., Kokara, M., Jarrett, A., Panicker, A., Kimani, P., Sadlowski, C., & Osman, F. (2026) · Open Heart · doi:10.1136/openhrt-2026-004137
Selected Disorders of the Cardiovascular System
Allen, P., Nguyen, K., & Dooley, P. T. (2026) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_89-3
Treatment of obstructive hypertrophic cardiomyopathy: the role of modern imaging and the place of surgery in the era of myosin inhibitors
Tregubova, M., Rudenko, K. V., Ткаченко, М. М., Danchenko, P. A., & Bei, A. O. (2026) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2026.4.358600
Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report
Scholtz, S., Langkamp, F., Rudolph, V., Federspiel, J. M., & Sequeira, V. (2026) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2026.06.011
Treating the sarcomere, respecting the geometry: mitral valve determinants of response to mavacamten in obstructive hypertrophic cardiomyopathy
Popescu, B. A., Cergan, B., & Roşca, M. (2026) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeag180
Aficamten Reduces Eligibility for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy: Long-Term Outcomes from FOREST-HCMPreprint
Masri, A., Meder, B., Choudhury, L., García‐Pavía, P., Abraham, T. P., Villa, R. B., Bilen, O., Elliot, P. M., Hagège, A. A., Nagueh, S. F., et al. (2026) · medRxiv · doi:10.64898/2026.07.08.26357594
Self-citation
Mavacamten's Dose‐Time Dynamics and Predictive Factors in Hypertrophic Obstructive Cardiomyopathy Cardiac Remodeling
Cao, B., Li, Y. M., & Chen, X. P. (2026) · Echocardiography · doi:10.1111/echo.70540
Differentiating Hypertrophic Cardiomyopathy from Athlete’s Heart: A Diagnostic Challenge in Sports Cardiology - A Narrative Review
Braksal, B., Cieślewicz, K., Częczek, K., Minik, B., Szymańska, K., Nowaczek, P., Mirkowski, K., Szurek, Z. W., Chyła, Z. J., & Miroński, A. (2026) · Quality in Sport · doi:10.12775/qs.2026.64.73026
Early Hemodynamic Vulnerability Despite Left Ventricular Outflow Tract Gradient Relief After Percutaneous Intramyocardial Septal Radiofrequency Ablation
Liu, Z., Ruan, X., Huang, X., Tang, X., & Huang, W. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.07.029
The Innocent Delta Wave in Progressive Cardiomyopathy – Culprit vs Bystander
Ansari, A. G., Shanmugam, S., Vijay, J., & Namboodiri, N. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.07.012
Rationale and design of the TAILOR-HCM multicenter randomized controlled trial: Transapical beating-heart septal myectomy for obstructive hypertrophic cardiomyopathy
Fang, J., Ma, Y., Chen, Y., Lai, Y., Wang, C., Guo, H., Ma, L., Yan, X., Wang, D., Wan, S., et al. (2026) · American Heart Journal · doi:10.1016/j.ahj.2026.107543
Diagnosis and management of hypertrophic obstructive cardiomyopathy complicated with subacute infective endocarditis: A case report
Wang, L., Zhu, J., Zhan, R., & Guo, Z. (2026) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2026.07.012
Beyond the N-terminus: Emerging regulatory roles of the middle and C-terminal domains of cardiac myosin binding protein-C
Crosby, G., Colson, B. A., Tong, C. W.-C., Harris, S. P., & Sadayappan, S. (2026) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2026.07.013
Association between triglyceride glucose–body mass index and clinical outcomes after septal myectomy
Song, C., Zheng, X., Cui, J., Yang, Q., Shuiyun, & Huang, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1855510
Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Leveraging Quantitative Imaging and Artificial Intelligence for Precision Management
Yang, Y., Bao, Y., Zhang, J., & Liu, Y. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm49021
Predictors of appropriate implantable cardioverter-defibrillator therapy in noncompaction cardiomyopathy
Dreher, L. A., Raslan, M. A., Nabi, H. A., Baqal, O. J., Osundiji, M. A., & Masry, H. E. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.07.027
Bibliometric and visualized analysis of research trends and knowledge structure in novel pharmacological treatments for hypertrophic cardiomyopathy
Chen, Z., Ai, F., Li, J., Cheng, B., Cheng, W., & Li, Y. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-04555-2
Coronary Flow in Hypertrophic Obstructive Cardiomyopathy-Immediate Effects of Alcohol Septal Ablation.
Mišević, V., Goločevac, A., Krupnikovic, K. S., Timčić, S., Arnautovic, N., Radoicic, D. D., Dobric, M. R., Mandić, A., Živković, S., Obradović, A. D., et al. (2026) · PubMed · doi:10.1002/ccd.70791
Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy
Federspiel, J. M., Medarev, S. L., Pfeifer, J., Jani, V., Pinto, J. R., & Landim-Vieira, M. (2026) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2026.100859
Exercise and Sport Participation in Pediatric Hypertrophic Cardiomyopathy: A Changing Paradigm
Russell, W., & Edelson, J. B. (2026) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-026-01150-5
Impact of Severe Postoperative Multi‐Organ Dysfunction on Long‐Term Outcomes After Modified Morrow Surgery
Wang, T., Ta, L., Zhang, K., Dong, R., Yu, X., & Wang, J. (2026) · Clinical Cardiology · doi:10.1002/clc.70434
Clinical characteristics, treatment patterns, and costs among hospitalised patients with cardiomyopathy: a multicentre retrospective tertiary-hospital study across China
Wang, L., Wang, C., Zheng, Y., Li, P., Huang, K., Jiang, X., Li, H., Zheng, Z., Li, W., Qin, F., et al. (2026) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2026.101943
Pattern of use of conventional medical treatments of heart failure with reduced ejection fraction in end-stage hypertrophic cardiomyopathy
Tini, G., Perlati, I., Palma, S., Giovani, S., Santolamazza, C., Monda, E., Vagnarelli, F., Marini, M., Bertero, E., Michieli, L. D., et al. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134721
Beyond the “Benign” Label: Toward Phenotype-Specific Risk Stratification in Apical Hypertrophic Cardiomyopathy
Chan, C.-H., & Chung, F. (2026) · Korean Circulation Journal · doi:10.4070/kcj.2026.0253
Severe mitochondrial cardiomyopathy with m.3303C > T variant in the mitochondrial tRNALeu(UUR) gene: A study of large family analysis
Yatsuga, S. (2026) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2026.101348
Clinical Characteristics and Emergency Response to Sudden Cardiac Arrest/Death Secondary to Cardiomyopathies in Young Athletes
Petek, B. J., Weller, S. L., Churchill, T. W., Maleszewski, J. J., Delong, R., Goettsch, B. P., Kucera, K. L., Harmon, K. G., & Drezner, J. A. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103093
Heterogeneity and Detection Rate of Hypertrophic Cardiomyopathy Phenotype in China: A Multicenter Echocardiography Study
Wang, B., Wang, B., Sun, H., Zhu, M., Yao, F., Lu, W., Wang, S., Wang, J., Shi, Y. Q., Xie, M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15166230

Authors: Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., Joglar, J. A., Khan, S. S., Kim, J. J., Kittleson, M. M., Krittanawong, C., Martinez, M. W., Mital, S., Naidu, S. S., Saberi, S., Semsarian, C., Times, S., & Waldman, C. B.
Affiliations: American Medical Society for Sports Medicine (US)
HRS representative.
Lay stakeholder representative.
AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
American Hospital Association (US)
PACES representative.
Joint ACC/AHA staff representative.
ORCID: Ommen, Steve R.
Ho, Carolyn Y.
Asif, Irfan M.
Balaji, Seshadri
Burke, Michael A.
Day, Sharlene M.
Dearani, Joseph A.
Ferrari, Victor A.
Joglar, José A.
Khan, Sadiya S.
Kim, Jeffrey J.
Kittleson, Michelle M.
Krittanawong, Chayakrit
Martinez, Matthew W.
Mital, Seema
Naidu, Srihari S.
Saberi, Sara
Semsarian, Christopher
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2024-06-04
Volume: 149
Issue: 23
Pages: e1239-e1311
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000001250
OpenAlex: W4396750647
Cited by: 807
References: 514
Citations by year: 2026: 353 · 2025: 372 · 2024: 82
FWCI: 226.55
Type: journal article
Language: en
Update notices: correction (2024-08-19)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, disease management, inherited heart disease, diagnosis, treatment guidelines, American Heart Association, American College of Cardiology, American Society of Echocardiography
MeSH terms: American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Humans, United States, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks